Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-266437

Director acquired 1,429 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
JEFFS ROGER Director 2026-06-08 Option exercise +1,429 58,939 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
JEFFS ROGER Director 2026-06-08 Option exercise · Restricted Stock Units −1,429 0 D: show line 2 in the form
Loading xslF345X06/ownership.xml…